SCHEMBL3040904

SCHEMBL3040904

CCOC(=O)/C=C/c1cc2c(s1)C(=C1CCN(C)CC1)c1ccccc1CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.47
MEN1 O00255 2/20 0.47
MAPT P10636 2/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
KDM4E B2RXH2 2/20 0.47
HPGD P15428 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
SETD7 Q8WTS6 1/20 0.46
HRH1 P35367 6/20 0.46
CHRM2 P08172 5/20 0.42
HTR2A P28223 5/20 0.42
CHRM1 P11229 4/20 0.42
HTR2C P28335 4/20 0.42
LMNA P02545 4/20 0.42
DRD2 P14416 3/20 0.42
ADRA2A P08913 3/20 0.42
ADRA2B P18089 3/20 0.42
DRD1 P21728 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3040906 1.00 MAPK1 (0.47) MAPK1MEN1MAPTKMT2AALDH1A1
SCHEMBL3042887 0.90 MAPK1 (0.45) MAPK1MEN1MAPTKMT2AALDH1A1
Hydrochloric Acid SCHEMBL3043688 0.87 MAPT (0.48) MAPK1MAPTALDH1A1TDP1KDM4E
Hydrochloric Acid SCHEMBL3043690 0.87 MAPT (0.48) MAPK1MAPTALDH1A1TDP1KDM4E
Hydrochloric Acid SCHEMBL3040291 0.87 MAPK1 (0.52) MAPK1MEN1MAPTKMT2AALDH1A1
Hydrochloric Acid SCHEMBL3040296 0.87 MAPK1 (0.52) MAPK1MEN1MAPTKMT2AALDH1A1
SCHEMBL3042843 0.86 MAPK1 (0.60) MAPK1MEN1MAPTKMT2AALDH1A1
SCHEMBL3042840 0.86 MAPK1 (0.60) MAPK1MEN1MAPTKMT2AALDH1A1
SCHEMBL3787497 0.85 DRD3 (0.55) MAPK1MEN1MAPTKMT2AALDH1A1
SCHEMBL3787498 0.85 DRD3 (0.55) MAPK1MEN1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243778-B1 PIPERIDINE DERIVATIVE NIPPON ZOKI PHARMACEUTICAL CO (JP) 2014-10-29 EP disclosed
US-8377967-B2 Piperidine derivative NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2013-02-19 US disclosed
US-20100331365-A1 PIPERIDINE DERIVATIVE NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2010-12-30 US disclosed
EP-2243778-A1 PIPERIDINE DERIVATIVE Nippon Zoki Pharmaceutical Co., Ltd. (JP) 2010-10-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331365-A1 PIPERIDINE DERIVATIVE HRH4, HRH3, HRH2 MAPK1 3605/4885MEN1 4423/4885MAPT 2217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.